AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MALVERN INTERNATIONAL PLC

Share Issue/Capital Change Feb 21, 2019

7772_rns_2019-02-21_9c669126-3221-422f-9a65-b16498c9a88c.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7463Q

Malvern International PLC

21 February 2019

For immediate release                                                                                                                  

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Malvern International plc

("Malvern", the "Company" or the "Group") 

Result of the Placing

Further to the accelerated bookbuilding process announced earlier today, Malvern International plc is pleased to announce the results of the Placing. Due to demand, the size of the Placing has been increased to 15,150,000 New Ordinary Shares. The Placing was conducted at a price of 4 pence per New Ordinary Share. The Placing Price represents a discount of 11.1 per cent. to the closing price on 20 February 2019, the last trading day prior to this announcement.  

The gross proceeds of the Placing amounting to £606,000 (before expenses) will be used to provide the Group with additional working capital, as detailed in the Company's earlier announcement today.

Application for admission to trading on AIM for 15,150,000 New Ordinary Shares being issued has been made and Admission is expected to take place on 27 February 2019. The New Ordinary Shares will rank pari passu with the Existing Ordinary Shares in issue. The New Ordinary Shares will represent approximately 5.86 per cent. of the Enlarged Issued Share Capital on Admission.

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following the issue of the New Ordinary Shares, its issued ordinary share capital will comprise 258,576,293 Ordinary Shares of 1 pence each. All of the Ordinary Shares have equal voting rights and none of the Ordinary Shares are held in Treasury. The total number of voting rights in the Company will therefore be 258,576,293 on Admission. The above figure may be used by shareholders as the denominator for the calculations to determine if they are required to notify their interests in, or change to their interest in, the Company

Terms used in this Announcement shall have the meanings given to such terms in the definitions section of the appendix to the announcement made by the Company at 7.00 a.m. this morning.

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

Enquiries:
Malvern International plc www.malverninternational.com
Dr Sam Malafeh (Chief Executive Officer)

Navin Khattar (Non-Executive Director)
Via Walbrook PR

[email protected]
WH Ireland Limited (Nominated Adviser and Broker) www.whirelandcb.com
Mike Coe / Chris Savidge (Corporate Finance) +44 (0) 117 945 3470
Jasper Berry / Adam Pollock (Corporate Broking) +44 (0) 207 220 1666
Walbrook PR (Financial PR) [email protected]
Tom Cooper / Paul McManus +44 (0) 207 933 8780

+44 (0) 776 880 7631

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ROIBFLFLKLFXBBQ

Talk to a Data Expert

Have a question? We'll get back to you promptly.